nabu.science
MethodologyAboutContact

 

Reliability concern: This paper was retracted on 2023-02-14. See notice: 10.1155/2023/9853726.

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-60F303D4·Framework v5.0·Pipeline v0.4·Evaluated 01 Jun 2026·OECD: 3.2 Clinical medicine·Subfield: Radiology, Nuclear Medicine and Imaging·Basis: Full text·Type: Diagnostic accuracy study

Dynamic Enhanced Magnetic Resonance Imaging versus Ultrasonic Diffused Optical Tomography in Early Diagnosis of Breast Cancer.

Xue et al.Xue, Jiang·2022·Journal of healthcare engineering·10.1155/2022/4834594 ↗

In brief

Incremental single-centre diagnostic accuracy comparison of MRI and DOT for breast cancer, undermined by inadequate statistical methodology for its comparative claims.

ReliabilityConcerns4 of 4 checks completeRead the 3 entries ↓
Abstract

OBJECTIVE: To compare the application value of dynamic enhanced magnetic resonance imaging (MRI) and ultrasonic diffused optical tomography (DOT) in early diagnosis of breast cancer.

METHODS: The clinical data of 110 female patients with breast diseases treated in our hospital from June 2018 to June 2021 were selected for the retrospective analysis, and the patients were divided into the benign lesion group (n = 50) and breast cancer group (n = 60) according to the pathologic findings. All patients received dynamic enhanced MRI and ultrasonic DOT examinations for the observation of lesion morphology and analysis of relevant parameters, so as to scientifically evaluate the diagnostic value of dynamic enhanced MRI and ultrasonic DOT for early breast cancer.

RESULTS: The dynamic enhanced MRI examination found that the proportions of irregular shape, increased vascular shadow, obscure boundary, spicule sign, heterogeneous enhancement, etc. of lesion were significantly higher in the breast cancer group than in the benign lesion group (P < 0.05); parameters such as K trans, K ep, and V e were significantly higher in the breast cancer group than in the benign lesion group (P < 0.05); the ultrasonic DOT diagnosis found that the THC value was obviously lower in the benign lesion group than in the breast cancer group (P < 0.05); compared with the pathologic findings, it was believed that combined diagnosis had significantly higher diagnosis accuracy rate, sensitivity, specificity, positive predictive value and negative predictive value than the dynamic enhanced MRI and ultrasonic DOT diagnosis alone (P < 0.05); and after further analyzing the efficacy of the two diagnosis modalities in diagnosing early breast cancer by ROC curves, the result showed combined diagnosis > dynamic enhanced MRI > ultrasonic DOT.

CONCLUSION: Both dynamic enhanced MRI and ultrasonic DOT present higher diagnostic value to early breast cancer, of which dynamic enhanced MRI obtains results closer to the pathologic findings and has diagnostic efficacy higher than ultrasonic DOT. But the combination of the two can significantly improve the diagnosis accuracy rate for early breast cancer, presenting higher diagnostic value.

Strengths · Limitations

Strengths

#methodological rigour

Appropriate pathological reference standard with both modalities

All patients received puncture or surgical pathology confirmation within two weeks of imaging, and both MRI and DOT were applied to the same cohort, enabling direct paired comparison against a valid gold standard.

↳ Methods §§2.1, 2.4

#methodological rigour

Detailed imaging protocol enabling reproducibility assessment

The MRI scanning parameters (sequences, TR, TE, flip angle, layer thickness, contrast injection protocol) and DOT procedure are described with sufficient technical detail for partial replication.

↳ Methods §§2.2, 2.3

#contribution

Multi-parameter quantitative characterisation of both modalities

The paper reports quantitative DCE-MRI parameters (Ktrans, Kep, Ve) and DOT parameters (THC) alongside morphological features, providing multi-dimensional characterisation rather than relying on a single diagnostic criterion.

↳ Results §§3.2, 3.3; Tables 2-4

Limitations

#methodological rigour

Statistical methods inadequate for paired diagnostic comparisons

The Methods section describes only chi-square and t-tests, but the study's central claims compare sensitivity, specificity, and AUC across modalities applied to the same patients. Appropriate methods for paired diagnostic data (e.g., McNemar's test, DeLong's test) are neither described nor referenced.

↳ Methods §2.5; Results §§3.4-3.5

#contribution

Clinical recommendation disproportionate to evidence base

The conclusion recommends ultrasonic DOT as 'the primary screening method for early breast cancer,' but this recommendation is based on a single-centre retrospective study of 110 patients with no prospective validation, cost-effectiveness analysis, or external replication.

↳ Conclusion; Discussion §4.3

#methodological rigour

Single reader with no blinding or reliability assessment

MRI diagnosis was performed by one physician using an undefined 'double blind method.' No inter-rater reliability statistics are reported, and blinding to DOT results and pathology during MRI interpretation is not confirmed, which is a critical gap in diagnostic accuracy studies.

↳ Methods §2.2

Does this match your read? Add your assessment ↓

Withdrawn — shown for reference only

Nabu Commentary

This diagnostic accuracy study addresses a clinically relevant question — whether combining DCE-MRI and ultrasonic DOT improves early breast cancer detection — and provides comparative data against pathological confirmation in 110 patients. The detailed imaging protocol and use of an appropriate reference standard are methodological strengths. However, the central comparative claims (that combined diagnosis is statistically superior to either modality alone across multiple performance metrics) rest on statistical methods that are inadequately described: the paired nature of the diagnostic data requires methods beyond the chi-square and t-tests listed in Section 2.5. The absence of a defined combination rule for the combined diagnosis, single-reader MRI interpretation without inter-rater reliability, and a clinical recommendation that extends well beyond the evidence base further limit the paper's contribution. The quality and impact scores reflect a study that addresses a real clinical question with some technical competence but whose comparative conclusions cannot be fully evaluated given the methodological reporting gaps.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
2.7±0.2

Contribution
2.9

The paper provides a head-to-head comparison of DCE-MRI and ultrasonic DOT with combined-modality analysis against pathological confirmation, addressing a clinically relevant question. The contribution is incremental rather than field-shifting, and the conclusion recommending DOT as a 'primary screening method' substantially overstates what a single-centre retrospective study of 110 patients can support.

Discussion §4.3; Conclusion; Introduction

it is suggested that ultrasonic DOT should be considered as the primary screening method

Methodological Rigour
2.5

The study uses pathological confirmation as an appropriate reference standard and describes imaging protocols in detail (Methods §2.2), but the statistical methods (chi-square and t-tests, §2.5) are inadequate for comparing paired diagnostic performance metrics across modalities, and no inter-rater reliability assessment accompanies the single-reader MRI interpretation. The combination rule for the combined diagnosis is not specified.

Methods §§2.2, 2.5; Results §§3.4-3.5; Tables 5-6
Reporting
3.2

The paper follows a conventional structure with consistent table references and a clear narrative flow from rationale through results. Language precision is uneven, with misapplication of 'double blind method' for a single reader and clinical recommendations that are disproportionate to the evidence presented.

Methods §2.2; Discussion §4.3; Abstract

by 1 experienced MRI diagnostic physician in radiology department by the double blind method

Positioning
2.7

The paper situates itself within breast cancer imaging literature and acknowledges key limitations (retrospective design, small sample), but does not cite systematic reviews or meta-analyses, does not comply with or reference STARD guidelines for diagnostic accuracy reporting, and engages only superficially with the extensive existing evidence on DCE-MRI diagnostic performance.

Introduction; Discussion §§4.1-4.3; References

Reliability

Concerns4 of 4 checks


Internal CoherenceNoted

The paper is internally consistent at a surface level — numbers in the abstract match results, directional claims are consistent, and no statistical impossibilities were detected. However, the conclusion recommends DOT as a 'primary screening method' based on evidence that does not support such a strong clinical recommendation, constituting overclaiming beyond the study design.

Research ConductNoted

Ethics approval is declared by reference to the Declaration of Helsinki but no specific IRB or ethics committee approval number is provided, making it declared-but-unverified. No conflict of interest statement is present. Data availability is claimed but not repository-backed.

Flags: 2 declared / 5 total

Reference IntegrityClean

All 23 cited references resolved to real publications via PubMed, Crossref, or OpenAlex.

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordConcern

This paper was retracted on 2023-02-14. See notice: 10.1155/2023/9853726.

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Cancer and neoplasms · Breast cancer
Type of advanceEmpirical
Route to useSpecified
AdvanceConsolidates
BeneficiariesLarge
CitationsFWCI 0.7
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessPiloted
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The diagnostic performance of both modalities and their combination was demonstrated against pathology in a single-centre cohort of 110 patients, a one-site proof of concept without independent confirmation.

From the paper
“ultrasonic DOT should be considered as the primary screening method for early breast cancer in the clinic, supplemented by dynamic enhanced MRI”

The conclusion names the clinical setting and specifies how the findings should be applied, namely DOT as primary screening with MRI as supplement.

Pathway

Breast imaging services and radiologists could adopt combined ultrasonic DOT plus dynamic enhanced MRI protocols to raise early breast cancer diagnostic accuracy.

Barrier

The evidence rests on a small, single-centre retrospective sample with acknowledged selection bias, requiring larger multicentre prospective validation before clinical adoption.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. How Does Diagnostic Accuracy Evolve with Increased Breast MRI Experience?

    Wu, Alikhassi, Curpen · 2023 · Clinical medicine

    Primary claim

    Diagnostic accuracy improved exponentially with increased MRI experience (definition B, OR of 1.27 and 1.61 for 5 and 10 years, respectively, p = 0.03 for both).

    Tentative
    Evidence Score
    2.3±0.1
    Reliability
    Caveats
  2. General cognitive function and the brain's structural connectome

    Buchanan, Moodie, Batziou, et al. · 2026 · Basic medicine

    Primary claim

    g is supported by a widely distributed white matter network whose macroscopic wiring capacity, microstructural organisation, and age sensitivity contribute in distinct ways.

    Tentative
    Evidence Score
    3.6±0.2
    Reliability
    Caveats
  3. The Dementias Platform UK PET/MR harmonisation and test-retest study: assessment of PET repeatability and reproducibility across the national network

    Markiewicz, Thompson, Wardlaw, et al. · 2026 · Clinical medicine

    Primary claim

    CL values across 74 scans showed excellent test-retest agreement (ICC = 0.968), improving to 0.987 after exclusion of one attenuation correction related outlier.

    Supported
    Evidence Score
    3.3±0.2
    Reliability
    Caveats

How the rubric works →